| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcf9d7dac3a69acf14ea77810bb74b25 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2001-2893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-884 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-86 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-86 |
| filingDate |
2019-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1778cd4fbb81d8f7f6b2446617ab95ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fb0286935a855550319e8897ad47a64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c94e0a6dca5fc74fbb52a0e2356c9e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f27fc47b68bc5bdf3dc5f86eea8319ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71f432f152001b2730e3ac481aa6fc61 |
| publicationDate |
2020-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-I706934-B |
| titleOfInvention |
A derivative of sodium phenylaminopropionate, a process for its preparation and use of the same |
| abstract |
The present invention discloses a derivative of sodium phenylaminopropionate, a process for its preparation and use of the same. nSpecifically, sodium 3-(4-(2-(9 H -carbazol-9-yl)ethoxy)phenyl)-2-((2-(4-(4-(2-sodium formate-2-((2-(4-fluorobenzoyl)phenyl)amino)ethyl)phenoxy)benzoyl) phenyl)amino)propionate as shown in formula (I), a process for its preparation and its use for quality control of bulk drugs or formulations of Chiglitazar or its derivatives are disclosed. In particular, the compound of formula (I) can be used as a control or standard for the detection of impurities/related substances in drugs of Chiglitazar or its sodium salt. |
| priorityDate |
2018-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |